MedPath

Clinical Study for the diagnosis of Eye infectio

Not Applicable
Suspended
Conditions
Health Condition 1: H36- Retinal disorders in diseases classified elsewhere
Registration Number
CTRI/2022/11/047357
Lead Sponsor
Proctor Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Presumed infectious anterior uveitis or intermediate uveitis or posterior uveitis or panuveitis

2. Presumed postoperative endophthalmitis

3. Unilateral or bilateral

Exclusion Criteria

1. Insufficient specimen for metagenomic deep sequencing ( <50 uL intraocular fluid)

2. Unable to give consent

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine if metagenomic deep sequencing changes treatment or clinical therapy <br/ ><br>Timepoint: 9 weeks <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Proportion of patients with clinical improvement at final visitTimepoint: 8 weeks <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath